Avanos Historical Financial Ratios

AVNS Stock  USD 15.06  0.15  0.99%   
Avanos Medical is presently reporting on over 112 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Ptb Ratio of 1.45, Days Sales Outstanding of 54.63 or Book Value Per Share of 32.46 will help investors to properly organize and evaluate Avanos Medical financial condition quickly.
Quick RatioCurrent Ratio2.37100%
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avanos Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Avanos Stock please use our How to Invest in Avanos Medical guide.

About Avanos Financial Ratios Analysis

Avanos MedicalFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Avanos Medical investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Avanos financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Avanos Medical history.

Avanos Medical Financial Ratios Chart

At this time, Avanos Medical's Capex To Revenue is comparatively stable compared to the past year. Cash Per Share is likely to gain to 2.46 in 2025, whereas Operating Cash Flow Per Share is likely to drop 0.76 in 2025.
Add Fundamental
Price To Sales RatioPtb Ratio
Days Sales OutstandingBook Value Per Share
Free Cash Flow YieldInvested Capital
Operating Cash Flow Per ShareAverage Payables
Stock Based Compensation To RevenueCapex To Depreciation
Pb RatioEv To Sales
Free Cash Flow Per ShareRoic
Inventory TurnoverNet Income Per Share
Days Of Inventory On HandPayables Turnover
Sales General And Administrative To RevenueAverage Inventory
Research And Ddevelopement To RevenueCapex To Revenue
Cash Per SharePocfratio
Interest CoveragePayout Ratio
Capex To Operating Cash FlowPfcf Ratio
Days Payables OutstandingNet Current Asset Value
Income QualityRoe
Tangible Asset ValueEv To Operating Cash Flow
Pe RatioReturn On Tangible Assets
Ev To Free Cash FlowIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Dividend YieldEarnings Yield
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity
JavaScript chart by amCharts 3.21.152016201820202022202411.21.41.61.822.22.42.62.833.23.4 0.911.11.21.31.41.51.6 4550556065707580859095100105110115 232425262728293031
JavaScript chart by amCharts 3.21.15Price To Sales Ratiototal: 23.68727951867985Ptb Ratiototal: 16.4352804926205Days Sales Outstandingtotal: 858.3562174925744Book Value Per Sharetotal: 328.1384031088188

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Avanos Medical stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Avanos Medical sales, a figure that is much harder to manipulate than other Avanos Medical multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.
Most ratios from Avanos Medical's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Avanos Medical current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avanos Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Avanos Stock please use our How to Invest in Avanos Medical guide.At this time, Avanos Medical's Capex To Revenue is comparatively stable compared to the past year. Cash Per Share is likely to gain to 2.46 in 2025, whereas Operating Cash Flow Per Share is likely to drop 0.76 in 2025.
 2022 2024 2025 (projected)
PTB Ratio0.980.971.45
Price To Sales Ratio1.551.41.49

Avanos Medical fundamentals Correlations

0.650.86-0.45-0.59-0.580.270.650.87-0.560.09-0.550.080.48-0.770.650.72-0.44-0.30.13-0.48-0.510.83-0.010.21-0.43
0.650.48-0.63-0.35-0.310.241.00.6-0.35-0.14-0.03-0.3-0.03-0.650.550.64-0.41-0.41-0.04-0.41-0.370.590.07-0.08-0.4
0.860.48-0.59-0.53-0.530.130.480.75-0.51-0.08-0.67-0.120.63-0.880.630.62-0.26-0.420.06-0.3-0.220.79-0.180.02-0.26
-0.45-0.63-0.590.440.49-0.02-0.63-0.430.480.290.520.64-0.50.79-0.35-0.540.180.63-0.010.180.02-0.42-0.140.30.17
-0.59-0.35-0.530.440.95-0.63-0.35-0.40.990.20.640.33-0.610.66-0.71-0.730.230.190.020.280.24-0.560.280.170.23
-0.58-0.31-0.530.490.95-0.41-0.31-0.320.980.30.770.32-0.730.67-0.56-0.680.250.220.180.320.17-0.520.270.260.26
0.270.240.13-0.02-0.63-0.410.240.35-0.550.20.05-0.1-0.05-0.260.750.640.140.050.370.12-0.260.45-0.190.190.16
0.651.00.48-0.63-0.35-0.310.240.6-0.35-0.14-0.03-0.3-0.03-0.650.550.64-0.41-0.41-0.04-0.41-0.370.590.07-0.08-0.4
0.870.60.75-0.43-0.4-0.320.350.6-0.340.46-0.350.110.35-0.640.560.62-0.41-0.230.55-0.41-0.640.70.110.52-0.38
-0.56-0.35-0.510.480.990.98-0.55-0.35-0.340.270.680.35-0.650.67-0.65-0.740.210.220.110.270.18-0.550.30.240.22
0.09-0.14-0.080.290.20.30.2-0.140.460.270.180.62-0.090.22-0.09-0.01-0.090.260.83-0.07-0.570.00.230.98-0.04
-0.55-0.03-0.670.520.640.770.05-0.03-0.350.680.180.21-0.980.62-0.21-0.370.30.350.060.360.15-0.350.130.150.31
0.08-0.3-0.120.640.330.32-0.1-0.30.110.350.620.21-0.180.31-0.17-0.130.050.380.20.02-0.310.030.110.740.06
0.48-0.030.63-0.5-0.61-0.73-0.05-0.030.35-0.65-0.09-0.98-0.18-0.580.160.33-0.31-0.340.04-0.36-0.170.3-0.16-0.07-0.31
-0.77-0.65-0.880.790.660.67-0.26-0.65-0.640.670.220.620.31-0.58-0.73-0.830.140.60.040.180.12-0.830.140.140.14
0.650.550.63-0.35-0.71-0.560.750.550.56-0.65-0.09-0.21-0.170.16-0.730.850.09-0.290.020.05-0.120.82-0.21-0.010.1
0.720.640.62-0.54-0.73-0.680.640.640.62-0.74-0.01-0.37-0.130.33-0.830.850.01-0.370.1-0.03-0.210.89-0.140.080.03
-0.44-0.41-0.260.180.230.250.14-0.41-0.410.21-0.090.30.05-0.310.140.090.010.11-0.130.990.770.010.12-0.091.0
-0.3-0.41-0.420.630.190.220.05-0.41-0.230.220.260.350.38-0.340.6-0.29-0.370.110.110.12-0.01-0.3-0.10.250.11
0.13-0.040.06-0.010.020.180.37-0.040.550.110.830.060.20.040.040.020.1-0.130.11-0.09-0.540.070.20.75-0.08
-0.48-0.41-0.30.180.280.320.12-0.41-0.410.27-0.070.360.02-0.360.180.05-0.030.990.12-0.090.78-0.030.14-0.080.99
-0.51-0.37-0.220.020.240.17-0.26-0.37-0.640.18-0.570.15-0.31-0.170.12-0.12-0.210.77-0.01-0.540.78-0.17-0.01-0.590.74
0.830.590.79-0.42-0.56-0.520.450.590.7-0.550.0-0.350.030.3-0.830.820.890.01-0.30.07-0.03-0.17-0.240.120.01
-0.010.07-0.18-0.140.280.27-0.190.070.110.30.230.130.11-0.160.14-0.21-0.140.12-0.10.20.14-0.01-0.240.230.14
0.21-0.080.020.30.170.260.19-0.080.520.240.980.150.74-0.070.14-0.010.08-0.090.250.75-0.08-0.590.120.23-0.04
-0.43-0.4-0.260.170.230.260.16-0.4-0.380.22-0.040.310.06-0.310.140.10.031.00.11-0.080.990.740.010.14-0.04
Click cells to compare fundamentals

Avanos Medical Account Relationship Matchups

Avanos Medical fundamentals Accounts

202020212022202320242025 (projected)
Price To Sales Ratio2.33.072.241.551.41.49
Ptb Ratio1.751.320.980.850.971.45
Days Sales Outstanding85.7457.9474.7477.4170.4754.63
Book Value Per Share26.2926.2827.5326.5330.5132.46
Free Cash Flow Yield(0.0104)0.03980.05640.0140.01610.0295
Operating Cash Flow Per Share(0.0523)1.811.940.70.80.76
Stock Based Compensation To Revenue0.01690.01770.01940.02350.02110.0222
Capex To Depreciation1.370.470.550.40.390.37
Pb Ratio1.751.320.980.850.971.45
Ev To Sales2.473.262.331.730.09090.0863
Free Cash Flow Per Share(0.47)1.381.530.310.360.34
Roic(0.0135)0.0053740.03540.003558(0.41)(0.39)
Net Income Per Share(0.57)0.131.08(1.33)(1.53)(1.45)
Days Of Inventory On Hand180.52144.25187.73202.89165.29113.57
Payables Turnover5.056.745.455.215.646.25
Research And Ddevelopement To Revenue0.04880.04340.03730.04040.03810.0295
Capex To Revenue0.02830.02820.02350.02640.02590.0422
Cash Per Share4.312.332.462.721.881.69
Pocfratio(877.23)19.113.9632.2637.138.95
Interest Coverage(2.96)2.77.40.2832.4830.85
Capex To Operating Cash Flow(8.08)0.240.210.550.180.19
Pfcf Ratio(96.61)25.1517.7371.5982.3386.45
Days Payables Outstanding72.2554.1366.9869.9964.6670.09
Income Quality0.091916.791.8(0.52)(0.26)(0.24)
Roe(0.0216)0.0049850.0391(0.05)(0.47)(0.45)
Ev To Operating Cash Flow(932.15)19.8915.6436.010.620.65
Pe Ratio(80.63)264.725.13(16.91)(15.22)(14.46)
Return On Tangible Assets(0.0382)0.0096660.0705(0.0941)(0.67)(0.64)
Ev To Free Cash Flow(102.66)26.1919.8579.910.750.72
Intangibles To Total Assets0.550.570.590.60.490.62
Net Debt To E B I T D A(68.65)7.751.962.4(0.16)(0.17)
Current Ratio2.532.813.012.692.082.37
Tangible Book Value Per Share6.26.684.714.314.955.47
Graham Number18.358.825.8328.1432.3635.68
Shareholders Equity Per Share26.2926.2827.5326.5330.5132.46
Debt To Equity0.20.150.220.170.210.29
Capex Per Share1.041.060.420.440.410.38

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Avanos Stock Analysis

When running Avanos Medical's price analysis, check to measure Avanos Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avanos Medical is operating at the current time. Most of Avanos Medical's value examination focuses on studying past and present price action to predict the probability of Avanos Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avanos Medical's price. Additionally, you may evaluate how the addition of Avanos Medical to your portfolios can decrease your overall portfolio volatility.